20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

News

BioGenerator News

BioGenerator Company Adarza BioSystems Closes $17M Series C

Jan 19, 2017

ROCHESTER, NY and ST LOUIS, MO Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from […]

Read More

AstraZeneca acquires antithrombotic from BioGenerator Company APT Therapeutics

Jan 05, 2017

AstraZeneca and APT Therapeutics have signed a research collaboration, option, and asset deal focused on the development of APT’s lead human recombinant apyrase therapy, APT102, for the treatment of thrombotic […]

Read More

BioGenerator Company Tioma Therapeutics Raises $86M

Aug 16, 2016

Funding Includes Support of Clinical Development of Anti-CD47 Antibody Program in Multiple Cancer Immunotherapy Trials Executive Team Headed by Biotech Industry Veteran John Donovan St. Louis, MO and Brisbane, CA […]

Read More

BioGenerator Company MediBeacon Acquires Mannheim Pharma & Diagnostics

Jun 14, 2016

Technology enables kidney function measurement in preclinical applications St. LOUIS – June 8, 2016 – St. Louis-based MediBeacon™ Inc., maker of proprietary, non-invasive, real-time monitoring systems for kidney function, gastrointestinal […]

Read More

2015 BioGenerator Annual Report Release

May 19, 2016

Read about BioGenerator’s 2015 investments, support activities and portfolio companies updates.

Read More

BioGenerator Invests in Innovative Health IT Company, MedAware Solutions

Mar 22, 2016

BioGenerator, an evergreen investor that creates, grows and invests in promising companies and entrepreneurs, has made an investment into MedAware Solutions, Inc. MedAware offers a comprehensive solution for empowering care teams, […]

Read More

BioGenerator Invests in New Immunotherapy Company, Unleash

Feb 18, 2016

Company will open operations in St. Louis BioGenerator, an evergreen investor that creates, grows and invests in promising companies and entrepreneurs, has made an investment from its Concept Fund into […]

Read More

BioGenerator Portfolio Company Galera Therapeutics Raises $42 Million Series B

Feb 05, 2016

Galera Therapeutics, Inc., a BioGenerator portfolio company focused on developing new treatments for cancer patients, recently announced the completion of a $42 million Series B financing. The proceeds of the […]

Read More

BioGenerator Leads Investment in Accuronix Therapeutics

Jan 27, 2016

Company developing pharmaceuticals to treat the most difficult cancers BioGenerator, an evergreen investor that creates, grows and invests in promising companies and entrepreneurs, has led a $625,000 investment round in […]

Read More

BioGenerator Invests in $800,000 Round for Ag Biotech Company, Edison Agrosciences

Jan 25, 2016

Company will move to St. Louis as part of financing BioGenerator, an evergreen investor that creates, grows and invests in promising companies and entrepreneurs, has made a pre-seed investment into […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors